Twist Bioscience Launched Synthetic RNA Control for H5N1 Influenza A
On Jul. 9, 2024, Twist Bioscience announced the expansion of its growing portfolio of synthetic viral controls with…
On Jul. 9, 2024, Twist Bioscience announced the expansion of its growing portfolio of synthetic viral controls with…
On Jun. 10, 2024, Roche announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use…
On Apr. 10, 2024, LabCorp announced announced that the U.S. Food and Drug Administration (FDA) had granted Emergency…
On Jul. 24, 2023, the United Arab Emirates (UAE), notified WHO of a case of Middle East Respiratory…
On Jan. 25, 2023, Roche and its subsidiary TIB Molbiol announced they had developed a COVID-19 PCR test…
On Jan. 9, 2023, BD (Becton, Dickinson) and CerTest Biotec have announced Emergency Use Authorization (EUA) from the…
On Nov. 15, 2022, Roche announced that the U.S. Food and Drug Administration had granted Emergency Use Authorization…
On Oct. 7, 2022, the U.S. Food and Drug Administration issued an Emergency Use Authorizationto Abbott Molecular, Inc.,…
On Jul. 27, 2022, BD (Becton, Dickinson) announced their newly developed molecular polymerase chain reaction (PCR) test for…
On Jul 14. 2022, Aegis Sciences announced it is was authorized to begin testing for monkeypox using the…
On Jul 13. 2022, Quest Diagnostics announced the nationwide availability of the company’s lab-developed molecular diagnostic test to…
On Jun. 15, 2022, Roche announced that the US Food and Drug Administration had issued Emergency Use Authorization…
On May 26, 2022, BD (Becton, Dickinson) announced a new high-throughput molecular diagnostic combination test for SARS-CoV-2 and…
On Mar. 30, 2022, Lucira Health announced that preliminary clinical trial results for its candidate COVID-19 & Flu…
On Feb. 24, 2022, Novavax shared extended analysis from its pivotal Phase 3 clinical trial conducted in the…
On Dec. 27, 2021, Sorrento Therapeutics announced that initial testing of COVISTIX on recombinant N proteins demonstrated its…
On Dec. 1, 2021, Fulgent Genetics confirmed that the Companyï¾’s RT-PCR test for SARS-CoV-2, the virus that causes…
On Nov. 30, 2021, LabCorp announced that it had begun offering observed self-collection for COVID-19 PCR testing in…
On Nov. 29, 2021, Thermo Fisher Scientific confirmed that its polymerase chain reaction (PCR) TaqPath COVID-19 Combo Kit…
On Oct. 7, 2021, PerkinElmer announced that the U.S. Food and Drug Administration (FDA) had issued Emergency Use…
On Sept. 1, 2021, Quidel announced it will make Quidelï¾’s non-prescription QuickVueï¾® At-Home OTC COVID-19 Test available to…
On Aug. 6, 2021, BD (Becton, Dickinson) and CerTest Biotec announced the CE mark for a molecular test…
On Jul. 22, 2021, Twist Bioscience announced that it had started shipping its synthetic RNA reference controls for…
On Jul. 5, 2021, CerTest Biotec and BD announces addition of saliva to the CE Marked VIASURE SARS-CoV-2…
On Jun. 30, 2021, the National Institutes of Health announced a highly anticipated study that compared rapid antigen…
On Jun. 24, 2021, researchers from the University of Oxford released their findings about the so-called ムcorrelates of…
On Jun. 22, 2021, BioReference Laboratories, an OPKO Health company, announced a COVID-19 testing program for U.S. based…
On Jun. 8, 2021, LabCorp announced that its Pixel COVID-19 PCR Test Home Collection Kits were availavle in…
On May 24, 2021, Quidel announced that its Sofia’ SARS Antigen FIA was the first rapid antigen test…
On May 20, 2021, XPhyto announced that its distribution, storage and logistics partner, Max Pharm has begun the…